COVID-19: Registry Study Offers Reassurance That ECMO Can Help Sickest Patients
Data from the Extracorporeal Life Support Organization registry shows experienced centers should consider using extracorporeal membrane oxygenation to treat COVID-19-related respiratory failure.
You may also be interested in...
Inspira Goes Public To Develop Its Alternative To Mechanical Ventilation
The Israeli company raised $16m to support its Augmented Respiration Technology, a novel approach for delivering oxygen directly into the venous system. The company expects to earn FDA clearance for first product by 2023.
Getinge Sees Q1 Acute Care Orders Jump 96%, Plans Major Investment In ECMO
The Swedish company has seen a spike in orders of acute care products to treat COVID-19 patients and plans a multi-million investment to expand long-term ECMO production.
Medtronic Earns CE Mark For Affera Ablation System, Touts New PFA Results
Results of the PULSED AF trial confirm that Medtronic’s PulseSelect pulsed field ablation is safe and effective for atrial fibrillation ablation. The company will likely incorporate PulseSelect into its Affera cardiac mapping and ablation system, which will soon be available in Europe.